These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 18986737)

  • 1. Aging enhances the neuroinflammatory response and alpha-synuclein nitration in rats.
    Choi DY; Zhang J; Bing G
    Neurobiol Aging; 2010 Sep; 31(9):1649-53. PubMed ID: 18986737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of p38 and inducible nitric oxide synthase in the in vivo dopaminergic cells' degeneration induced by inflammatory processes after lipopolysaccharide injection.
    Ruano D; Revilla E; Gavilán MP; Vizuete ML; Pintado C; Vitorica J; Castaño A
    Neuroscience; 2006 Jul; 140(4):1157-68. PubMed ID: 16713109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrapallidal lipopolysaccharide injection increases iron and ferritin levels in glia of the rat substantia nigra and induces locomotor deficits.
    Zhang J; Stanton DM; Nguyen XV; Liu M; Zhang Z; Gash D; Bing G
    Neuroscience; 2005; 135(3):829-38. PubMed ID: 16165292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
    Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
    J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic expression of low levels of tumor necrosis factor-alpha in the substantia nigra elicits progressive neurodegeneration, delayed motor symptoms and microglia/macrophage activation.
    De Lella Ezcurra AL; Chertoff M; Ferrari C; Graciarena M; Pitossi F
    Neurobiol Dis; 2010 Mar; 37(3):630-40. PubMed ID: 19969084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration in alpha-synuclein mRNA expression in Parkinson's disease.
    Kingsbury AE; Daniel SE; Sangha H; Eisen S; Lees AJ; Foster OJ
    Mov Disord; 2004 Feb; 19(2):162-70. PubMed ID: 14978671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of alpha-synuclein expression can rescue dopaminergic cells from cell death in the substantia nigra of Parkinson's disease rat model.
    Hayashita-Kinoh H; Yamada M; Yokota T; Mizuno Y; Mochizuki H
    Biochem Biophys Res Commun; 2006 Mar; 341(4):1088-95. PubMed ID: 16460685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of age and gender on cytokine expression in a murine model of Parkinson's disease.
    Ciesielska A; Joniec I; Kurkowska-Jastrzebska I; Przybyłkowski A; Gromadzka G; Członkowska A; Członkowski A
    Neuroimmunomodulation; 2007; 14(5):255-65. PubMed ID: 18196934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-synuclein activates stress signaling protein kinases in THP-1 cells and microglia.
    Klegeris A; Pelech S; Giasson BI; Maguire J; Zhang H; McGeer EG; McGeer PL
    Neurobiol Aging; 2008 May; 29(5):739-52. PubMed ID: 17166628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease.
    Zecca L; Wilms H; Geick S; Claasen JH; Brandenburg LO; Holzknecht C; Panizza ML; Zucca FA; Deuschl G; Sievers J; Lucius R
    Acta Neuropathol; 2008 Jul; 116(1):47-55. PubMed ID: 18343932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased alpha-synuclein expression in the aging mouse substantia nigra.
    Mak SK; McCormack AL; Langston JW; Kordower JH; Di Monte DA
    Exp Neurol; 2009 Dec; 220(2):359-65. PubMed ID: 19800328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory priming of the substantia nigra influences the impact of later paraquat exposure: Neuroimmune sensitization of neurodegeneration.
    Mangano EN; Hayley S
    Neurobiol Aging; 2009 Sep; 30(9):1361-78. PubMed ID: 18187236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The acute inflammatory response to intranigral α-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation.
    Couch Y; Alvarez-Erviti L; Sibson NR; Wood MJ; Anthony DC
    J Neuroinflammation; 2011 Nov; 8():166. PubMed ID: 22122884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains.
    Imamura K; Hishikawa N; Sawada M; Nagatsu T; Yoshida M; Hashizume Y
    Acta Neuropathol; 2003 Dec; 106(6):518-26. PubMed ID: 14513261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic approaches to inflammation in neurodegenerative disease.
    Klegeris A; McGeer EG; McGeer PL
    Curr Opin Neurol; 2007 Jun; 20(3):351-7. PubMed ID: 17495632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly purified lipoteichoic acid induced pro-inflammatory signalling in primary culture of rat microglia through Toll-like receptor 2: selective potentiation of nitric oxide production by muramyl dipeptide.
    Kinsner A; Boveri M; Hareng L; Brown GC; Coecke S; Hartung T; Bal-Price A
    J Neurochem; 2006 Oct; 99(2):596-607. PubMed ID: 16879708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minocycline reduces the lipopolysaccharide-induced inflammatory reaction, peroxynitrite-mediated nitration of proteins, disruption of the blood-brain barrier, and damage in the nigral dopaminergic system.
    Tomás-Camardiel M; Rite I; Herrera AJ; de Pablos RM; Cano J; Machado A; Venero JL
    Neurobiol Dis; 2004 Jun; 16(1):190-201. PubMed ID: 15207276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new anti-inflammatory agent KL-1037 represses proinflammatory cytokine and inducible nitric oxide synthase (iNOS) gene expression in activated microglia.
    Kim WK; Jang PG; Woo MS; Han IO; Piao HZ; Lee K; Lee H; Joh TH; Kim HS
    Neuropharmacology; 2004 Aug; 47(2):243-52. PubMed ID: 15223303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.